Metal-organic framework nanoparticles induced non-apoptotic cell death: Construction, mechanisms, and cancer therapy

Shaoshi Ma1, Yingying Wei2,3, Yajie Li1

  • 1Medical Imaging Department of Shanxi Medical University, Taiyuan, 030001, PR China.

Materials Today. Bio
|April 30, 2026
PubMed

Insights

Metal-organic framework nanoparticles (MOF NPs) offer a promising strategy to overcome cancer therapy resistance by inducing non-apoptotic cell death. MOF NPs enhance drug delivery and tumor targeting, addressing limitations of current treatments.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Tumor resistance to apoptosis is a major challenge in cancer treatment.
  • Non-apoptotic cell death pathways (ferroptosis, pyroptosis, autophagy) show therapeutic potential.
  • Existing non-apoptotic inducers face issues with targeting, tumor enrichment, and toxicity.

Purpose of the Study:

  • To review the molecular mechanisms of various non-apoptotic cell death modalities.
  • To explore the application of Metal-Organic Framework Nanoparticles (MOF NPs) in inducing non-apoptotic cell death.
  • To summarize MOF NP design strategies and their efficacy in cancer therapy.

Main Methods:

  • Systematic review of literature on non-apoptotic cell death mechanisms.
  • Analysis of MOF NP properties relevant to drug delivery and cell death induction.
  • Summary of MOF NP design strategies (composition, functionalization, release).

Main Results:

  • MOF NPs demonstrate tunable structures and high drug loading capacity.
  • MOF NPs can efficiently deliver non-apoptotic inducers or directly trigger cell death.
  • MOF NPs show promise in targeted induction of ferroptosis, pyroptosis, autophagy, cuproptosis, and disulfidptosis.

Conclusions:

  • MOF NPs present a viable strategy to overcome therapeutic resistance by inducing non-apoptotic cell death.
  • Design strategies for MOF NPs can be tailored to specific non-apoptotic pathways.
  • Further research is needed to address challenges in biosafety, scalability, and clinical translation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
12.0K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99